Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corporation

The Strategy Shares Monopoly ETF (MPLY) is an actively managed fund that owns the U.S. equities Strategy Shares believes demonstrate durable compet...

Ten Structural Traits That Define a Monopoly: Inside the Screen Behind the Strategy Shares Monopoly ETF (MPLY)

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific is launching a new trial called “Metabolic Effects ...

Boston Scientific Targets Diabetes and Obesity With New ESG Trial

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific’s RESCUE study, formally titled “Evaluation of Endo...

Boston Scientific’s RESCUE Study Termination: What It Means for ESG and Obesity Investments

In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Boston Scientific, with a price target of $64.00. Accor...

Boston Scientific (BSX) Receives a Buy from Truist Financial

The SPDR S&P 500 ETF Trust ($SPY) jumped 0.56% on Thursday, May 28, driven primarily by geopolitical developments in the Middle East and strong cor...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/28/2026

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific (BSX) is running a multicenter study titled “A Mult...

Boston Scientific Advances FARAPULSE PFA Study in Atrial Fibrillation

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific Corporation is running a study called “A Study to E...

Boston Scientific Nears Key Data Milestone in Painful Diabetic Neuropathy Trial

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Wave Life Sciences (WVE) and Boston Scientific (BSX)...

Analysts Are Bullish on Top Healthcare Stocks: Wave Life Sciences (WVE), Boston Scientific (BSX)

Management provided a corporate update. 


Here’s Why Boston Scientific Stock (BSX) Is Crashing Today

Insiders have been trading these 5 stocks: (($BSX)), (($LITE)), (($MCHP)), (($ABR)) and (($JMIA)). Here is a breakdown of their recent trades and t...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BSX	$45.29	+0.76%	30.85M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BSX	$45.29	+0.8%	30.85M
3
4
5
6

BSX

BSX

No Data Available

Get Boston Scientific Corporation Data in Excel

Get Boston Scientific Corporation Data in Excel